TY - JOUR
T1 - Hypotensive Response to IV Acetaminophen in Pediatric Cardiac Patients
AU - Achuff, Barbara Jo
AU - Moffett, Brady S.
AU - Acosta, Sebastian
AU - Lasa, Javier J.
AU - Checchia, Paul A.
AU - Rusin, Craig G.
N1 - Funding Information:
Dr. Moffett disclosed off-label product use of IV Acetaminophen for use in critically ill pediatric patients. Dr. Rusin's institution received funding from the National Institutes of Health (NIH); he received funding from Medical Informatics Corp.; and he received support for article research from the NIH. The remaining authors have disclosed that they do not have any potential conflicts of interest.
Funding Information:
Dr. Moffett disclosed off-label product use of IV Acetaminophen for use in crit-atric Cardiology, Baylor College of Medicine, Houston, TX. Administration in November 2010 for the treatment of acute ically ill pediatric patients. Dr. Rusin’s institution received funding from the Na- pain and fever in children and adults, it has been frequently tional Institutes of Health (NIH); he received funding from Medical Informatics administered IV to patients undergoing major surgery and to authors have disclosed that they do not have any potential conflicts of interest.Corp.; and he received support for article research from the NIH. The remaining critically ill patients in whom enteral routes may not be pos-This work was performed at Texas Children’s Hospital, Baylor College of sible (3–5). Although widely believed to be safe and free of ad- Medicine. verse effects, the hemodynamic effects of this formulation are Address requests for reprints to: Barbara-Jo Achuff, MD, FAAP, Depart-largely understudied especially in pediatric patients. There is a ment of Pediatrics, Cardiac Critical Care, Baylor College of Medicine; growing body of literature in adult critical care settings raising 77030. E-mail: bachuff@bcm.eduTexas Children’s Hospital, 6651 Main Street, MC E1420, Houston, TX concern regarding the association of IV formulations of aceta-Copyright ©2019 by the Society of Critical Care Medicine and the World minophen and transient hypotension, especially significant de- Federation of Pediatric Intensive and Critical Care Societies crease in systolic and/or mean arterial pressure (MAP), and all DOI: 10.1097/PCC.0000000000001880 agree that such effects are underreported (6–14). This may be
Publisher Copyright:
© 2019 by the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
PY - 2019/6/1
Y1 - 2019/6/1
N2 - Objectives: Acetaminophen is ubiquitously used as antipyretic/analgesic administered IV to patients undergoing surgery and to critically ill patients when enteral routes are not possible. Widely believed to be safe and free of adverse side effects, concerns have developed in adult literature regarding the association of IV acetaminophen and transient hypotension. We hypothesize that there are hemodynamic effects after IV acetaminophen in the PICU and assess the prevalence of such in a large pediatric cardiovascular ICU population using high-fidelity data. Design: Observational study analyzing an enormous set of continuous physiologic data including millions of beat to beat blood pressures surrounding medication administration. Setting: Quaternary pediatric cardiovascular ICU between January 1, 2013, and November 13, 2017. Patients: All patients less than or equal to 18 years old who received IV acetaminophen. Mechanical support devices excluded. Interventions: None. Measurements and Main Results: Physiologic vital sign data were analyzed in 5-minute intervals starting 60 minutes before through 180 minutes after completion. Hypotension defined as mean arterial pressure -15% from baseline and relative hypotension defined -10%. Only doses where patients received no other medications, including vasopressors, within the previous hour were included. t test and a correlation matrix were used to eliminate correlated factors before a logistic regression analysis was performed. Six-hundred eight patients received 777 IV acetaminophen doses. Median age was 8.8 months (interquartile range, 2-62 mo) with a dose of 12.5 mg/kg (interquartile range, 10-15 mg/kg). Data were normalized for age and reference values. One in 20 doses (5%) were associated with hypotension, and one in five (20%) associated with relative hypotension. Univariate analysis revealed hypotension associated with age, baseline mean arterial pressure, and skin temperature (p = 0.05, 0.01, and 0.09). Logistic regression revealed mean arterial pressure (p = 0.01) and age (p = 0.05) remained predictive for hypotension. Conclusions: In isolation of other medication, a hemodynamic response to IV acetaminophen has a higher prevalence in critically ill children with cardiac disease than previously thought and justifies controlled studies in the perioperative and critical care setting. The added impact on individual patient hemodynamics and physiologic instability will require further study.
AB - Objectives: Acetaminophen is ubiquitously used as antipyretic/analgesic administered IV to patients undergoing surgery and to critically ill patients when enteral routes are not possible. Widely believed to be safe and free of adverse side effects, concerns have developed in adult literature regarding the association of IV acetaminophen and transient hypotension. We hypothesize that there are hemodynamic effects after IV acetaminophen in the PICU and assess the prevalence of such in a large pediatric cardiovascular ICU population using high-fidelity data. Design: Observational study analyzing an enormous set of continuous physiologic data including millions of beat to beat blood pressures surrounding medication administration. Setting: Quaternary pediatric cardiovascular ICU between January 1, 2013, and November 13, 2017. Patients: All patients less than or equal to 18 years old who received IV acetaminophen. Mechanical support devices excluded. Interventions: None. Measurements and Main Results: Physiologic vital sign data were analyzed in 5-minute intervals starting 60 minutes before through 180 minutes after completion. Hypotension defined as mean arterial pressure -15% from baseline and relative hypotension defined -10%. Only doses where patients received no other medications, including vasopressors, within the previous hour were included. t test and a correlation matrix were used to eliminate correlated factors before a logistic regression analysis was performed. Six-hundred eight patients received 777 IV acetaminophen doses. Median age was 8.8 months (interquartile range, 2-62 mo) with a dose of 12.5 mg/kg (interquartile range, 10-15 mg/kg). Data were normalized for age and reference values. One in 20 doses (5%) were associated with hypotension, and one in five (20%) associated with relative hypotension. Univariate analysis revealed hypotension associated with age, baseline mean arterial pressure, and skin temperature (p = 0.05, 0.01, and 0.09). Logistic regression revealed mean arterial pressure (p = 0.01) and age (p = 0.05) remained predictive for hypotension. Conclusions: In isolation of other medication, a hemodynamic response to IV acetaminophen has a higher prevalence in critically ill children with cardiac disease than previously thought and justifies controlled studies in the perioperative and critical care setting. The added impact on individual patient hemodynamics and physiologic instability will require further study.
KW - congenital heart defects
KW - critical care
KW - drug-related side effects and adverse reactions
KW - hemodynamics
KW - patient generated clinical data
KW - pediatric
UR - http://www.scopus.com/inward/record.url?scp=85065422310&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85065422310&partnerID=8YFLogxK
U2 - 10.1097/PCC.0000000000001880
DO - 10.1097/PCC.0000000000001880
M3 - Article
C2 - 30676493
AN - SCOPUS:85065422310
SN - 1529-7535
VL - 20
SP - 527
EP - 533
JO - Pediatric Critical Care Medicine
JF - Pediatric Critical Care Medicine
IS - 6
ER -